APA

de Jager C. P. C., Wever P. C., Gemen E. F. A., van Oijen M. G. H., van Gageldonk-Lafeber A. B., Siersema P. D., Kusters G. C. M. & Laheij R. J. F. (20130320). Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia. : Alimentary pharmacology & therapeutics.

Chicago

de Jager C P C, Wever P C, Gemen E F A, van Oijen M G H, van Gageldonk-Lafeber A B, Siersema P D, Kusters G C M and Laheij R J F. 20130320. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia. : Alimentary pharmacology & therapeutics.

Harvard

de Jager C. P. C., Wever P. C., Gemen E. F. A., van Oijen M. G. H., van Gageldonk-Lafeber A. B., Siersema P. D., Kusters G. C. M. and Laheij R. J. F. (20130320). Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia. : Alimentary pharmacology & therapeutics.

MLA

de Jager C P C, Wever P C, Gemen E F A, van Oijen M G H, van Gageldonk-Lafeber A B, Siersema P D, Kusters G C M and Laheij R J F. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia. : Alimentary pharmacology & therapeutics. 20130320.